This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Skinner AC, Ravanbakht SN, Skelton JA, Perrin EM, Armstrong SC: Prevalence of obesity and severe obesity in US children, 1999–2016. Pediatrics 2018; 141: e20173459.SkinnerACRavanbakhtSNSkeltonJAPerrinEMArmstrongSC:Prevalence of obesity and severe obesity in US children, 1999–2016.Pediatrics2018;141:e20173459.10.1542/peds.2017-3459610960229483202Search in Google Scholar
Dyson JK, McPherson S, Anstee QM: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. J Clin Pathol 2013; 66: 1033–1045.DysonJKMcPhersonSAnsteeQM:Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification.J Clin Pathol2013;66:1033–1045.10.1136/jclinpath-2013-20162023940130Search in Google Scholar
Goyal NP, Schwimmer JB: The genetics of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2018; 22: 59–71.GoyalNPSchwimmerJB:The genetics of pediatric nonalcoholic fatty liver disease.Clin Liver Dis2018;22:59–71.10.1016/j.cld.2017.08.002569330729128061Search in Google Scholar
Alisi A, Feldstein AE, Villani A, Raponi M, Nobili V: Pediatric nonalcoholic fatty liver disease: A multidisciplinary approach. Nat Rev Gastroenterol Hepatol 2012; 9: 152–161.AlisiAFeldsteinAEVillaniARaponiMNobiliV:Pediatric nonalcoholic fatty liver disease: A multidisciplinary approach.Nat Rev Gastroenterol Hepatol2012;9:152–161.10.1038/nrgastro.2011.27322249728Search in Google Scholar
Pan JJ, Fallon MB: Gender and racial differences in nonalcoholic fatty liver disease. World J Hepatol 2014; 6: 274–283.PanJJFallonMB:Gender and racial differences in nonalcoholic fatty liver disease.World J Hepatol2014;6:274–283.10.4254/wjh.v6.i5.274403328524868321Search in Google Scholar
Anderson EL, Howe LD, Jones HE, Higgins JPT, Lawlor DA, Fraser A: The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis. PloS One 2015; 10: e0140908.AndersonELHoweLDJonesHEHigginsJPTLawlorDAFraserA:The prevalence of non-alcoholic fatty liver disease in children and adolescents: A systematic review and meta-analysis.PloS One2015;10:e0140908.10.1371/journal.pone.0140908462602326512983Search in Google Scholar
Nobili V, Vizzutti F, Arena U, Abraldes JG, Marra F, Pietrobattista A et al.: Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis. Hepatology 2008; 48: 442–448.NobiliVVizzuttiFArenaUAbraldesJGMarraFPietrobattistaA:Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.Hepatology2008;48:442–448.10.1002/hep.2237618563842Search in Google Scholar
Armstrong T, Ly KV, Murthy S, Ghahremani S, Kim GH, Calkins KL et al.: Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique. Pediatr Radiol 2018; 48: 941–953.ArmstrongTLyKVMurthySGhahremaniSKimGHCalkinsKL:Free-breathing quantification of hepatic fat in healthy children and children with nonalcoholic fatty liver disease using a multi-echo 3-D stack-of-radial MRI technique.Pediatr Radiol2018;48:941–953.10.1007/s00247-018-4127-729728744Search in Google Scholar
Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T et al.: Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease. Diabetes Obes Metab 2019; 21: 285–292.ShimizuMSuzukiKKatoKJojimaTIijimaTMurohisaT:Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.Diabetes Obes Metab2019;21:285–292.10.1111/dom.1352030178600Search in Google Scholar
Tolman KG, Fonseca V, Dalpiaz A, Tan MH: Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease. Diabetes Care 2007; 30: 734–743.TolmanKGFonsecaVDalpiazATanMH:Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease.Diabetes Care2007;30:734–743.10.2337/dc06-153917327353Search in Google Scholar
Byrne CD, Targher G: NAFLD: a multisystem disease. J Hepatol 2015; 62 Suppl: S47–S64.ByrneCDTargherG:NAFLD: a multisystem disease.J Hepatol2015;62Suppl:S47–S64.10.1016/j.jhep.2014.12.01225920090Search in Google Scholar
Trombetta M, Spiazzi G, Zoppini G, Muggeo M: Review article: type 2 diabetes and chronic liver disease in the verona diabetes study. Aliment Pharmacol Ther 2005; 22 Suppl: 24–27.TrombettaMSpiazziGZoppiniGMuggeoM:Review article: type 2 diabetes and chronic liver disease in the verona diabetes study.Aliment Pharmacol Ther2005;22Suppl:24–27.10.1111/j.1365-2036.2005.02590.x16225467Search in Google Scholar
de Lédinghen V, Le Bail B, Rebouissoux L, Fournier C, Foucher J, Miette V et al.: Liver stiffness measurement in children using FibroScan: Feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy. J Pediatr Gastroenterol Nutr 2007; 45: 443–450.de LédinghenVLe BailBRebouissouxLFournierCFoucherJMietteV:Liver stiffness measurement in children using FibroScan: Feasibility study and comparison with fibrotest, aspartate transaminase to platelets ratio index, and liver biopsy.J Pediatr Gastroenterol Nutr2007;45:443–450.10.1097/MPG.0b013e31812e56ff18030211Search in Google Scholar
Kim E, Kang Y, Hahn S, Lee MJ, Park YN, Koh H: The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice. Korean J Pediatr 2013; 56: 19–25.KimEKangYHahnSLeeMJParkYNKohH:The efficacy of aspartate aminotransferase-to-platelet ratio index for assessing hepatic fibrosis in childhood nonalcoholic steatohepatitis for medical practice.Korean J Pediatr2013;56:19–25.10.3345/kjp.2013.56.1.19356402623390441Search in Google Scholar
Shah J, Okubote T, Alkhouri N: Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease. Gastroenterol Hepatol (N Y) 2018; 14: 407–414.ShahJOkuboteTAlkhouriN:Overview of updated practice guidelines for pediatric nonalcoholic fatty liver disease.Gastroenterol Hepatol (N Y)2018;14:407–414.Search in Google Scholar
Fallatah HI, Akbar HO, Fallatah AM: Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease. Hepat Mon 2016; 16: e38346.FallatahHIAkbarHOFallatahAM:Fibroscan compared to FIB-4, APRI, and AST/ALT ratio for assessment of liver fibrosis in Saudi patients with nonalcoholic fatty liver disease.Hepat Mon2016;16:e38346.10.5812/hepatmon.38346501836127642348Search in Google Scholar
Mansoor S, Yerian L, Kohli R, Xanthakos S, Angulo P, Ling S et al.: The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease. Dig Dis Sci 2015; 60: 1440–1447.MansoorSYerianLKohliRXanthakosSAnguloPLingS:The evaluation of hepatic fibrosis scores in children with nonalcoholic fatty liver disease.Dig Dis Sci2015;60:1440–1447.10.1007/s10620-014-3494-725540086Search in Google Scholar
Joo I, Kim SY, Park HS, Lee ES, Kang HJ, Lee JM: Validation of a new point shear-wave elastography method for noninvasive assessment of liver fibrosis: a prospective multicenter study. Korean J Radiol 2019; 20: 1527–1535.JooIKimSYParkHSLeeESKangHJLeeJM:Validation of a new point shear-wave elastography method for noninvasive assessment of liver fibrosis: a prospective multicenter study.Korean J Radiol2019;20:1527–1535.10.3348/kjr.2019.0109679181431606957Search in Google Scholar
Lee CK, Perez-Atayde AR, Mitchell PD, Raza R, Afdhal NH, Jonas MM: Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a united states cohort: the boston children’s hospital experience. J Pediatr 2013; 163: 1058–1064.e2.LeeCKPerez-AtaydeARMitchellPDRazaRAfdhalNHJonasMM:Serum biomarkers and transient elastography as predictors of advanced liver fibrosis in a united states cohort: the boston children’s hospital experience.J Pediatr2013;163:1058–1064.e2.10.1016/j.jpeds.2013.04.04423759423Search in Google Scholar
Dhyani M, Gee MS, Misdraji J, Israel EJ, Shah U, Samir AE: Feasibility study for assessing liver fibrosis in paediatric and adolescent patients using real-time shear wave elastography. J Med Imaging Radiat Oncol 2015; 59: 687–694.DhyaniMGeeMSMisdrajiJIsraelEJShahUSamirAE:Feasibility study for assessing liver fibrosis in paediatric and adolescent patients using real-time shear wave elastography.J Med Imaging Radiat Oncol2015;59:687–694.10.1111/1754-9485.12388747455326503488Search in Google Scholar
Ferraioli G, Filice C, Castera L, Choi BI, Sporea I, Wilson SR et al.: WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver. Ultrasound Med Biol 2015; 41: 1161–1179.FerraioliGFiliceCCasteraLChoiBISporeaIWilsonSR:WFUMB guidelines and recommendations for clinical use of ultrasound elastography: part 3: liver.Ultrasound Med Biol2015;41:1161–1179.10.1016/j.ultrasmedbio.2015.03.00725800942Search in Google Scholar
ADA. American Diabetes Association Website. https://www.diabetes.org/a1c/diagnosis. Accessed: 6.01.2020.ADA.American Diabetes Association Website.https://www.diabetes.org/a1c/diagnosis. Accessed: 6.01.2020.Search in Google Scholar
Osman AM, El Shimy A, Abd El Aziz MM: 2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis. Insights Imaging 2020; 11: 38.OsmanAMEl ShimyAAbd El AzizMM:2D shear wave elastography (SWE) performance versus vibration-controlled transient elastography (VCTE/fibroscan) in the assessment of liver stiffness in chronic hepatitis.Insights Imaging2020;11:38.10.1186/s13244-020-0839-y706295832152802Search in Google Scholar
Lin ZH, Xin YN, Dong QJ, Wang Q, Jiang XJ, Zhan SH et al.: Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis. Hepatology 2011; 53: 726–736.LinZHXinYNDongQJWangQJiangXJZhanSH:Performance of the aspartate aminotransferase-to-platelet ratio index for the staging of hepatitis C-related fibrosis: an updated meta-analysis.Hepatology2011;53:726–736.10.1002/hep.2410521319189Search in Google Scholar